Reaction
Adhesion reporting signals
As of the last recalculation, Adhesion appears in 1,501 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB (PRR 11.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab | 437 | 11.7 | 11.7 |
| Diphenoxylate Hydrochloride And Atropine Sulfate | 11 | 11.2 | 11.2 |
| Teduglutide | 10 | 10.4 | 10.4 |
| Leucovorin Calcium | 12 | 8.8 | 8.8 |
| Leuprolide Acetate | 41 | 7.5 | 7.5 |
| Insulin Glulisine | 5 | 6.8 | 6.8 |
| Timolol | 5 | 5.8 | 5.8 |
| Risankizumab-Rzaa | 33 | 5.7 | 5.7 |
| Niraparib | 9 | 5.7 | 5.7 |
| Cortisone Acetate | 5 | 5.6 | 5.6 |
| Copper | 17 | 5.5 | 5.5 |
| Rucaparib | 3 | 4.7 | 4.7 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 6 | 2.7 | 2.7 |
| Lifitegrast | 3 | 2.5 | 2.5 |
| Etonogestrel | 7 | 2.0 | 2.0 |
| Levonorgestrel | 29 | 2.0 | 2.0 |